TABLE 1.
Single nucleotide variants
| Segment | Position (nt) a | Coding impact | Reference base | Variant base | P1 | P2 | P3 | P4 | P5 |
|---|---|---|---|---|---|---|---|---|---|
| L | 4665 | E1549E | A | G | 0.00 | 0.07 | 0.09 | 0.12 | 0.16 |
| L | 5483 | K1822M | A | T | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 |
| L | 5488 | D1824Y | G | T | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| L | 5513 | R1832I | G | T | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| L | 6113 | Y2032C | A | G | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 |
| M | 31 b | G3E | G | A | 0.00 | 0.00 | 0.00 | 0.25 | 0.54 |
| M | 32 b | G3G | G | A | 0.00 | 0.00 | 0.07 | 0.20 | 0.19 |
| M | 190 | G56E | G | A | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| M | 300 | K93E | A | G | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 |
| M | 457 | Y145C | A | G | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
| M | 462 | L147I | C | A | 0.00 | 0.06 | 0.09 | 0.09 | 0.00 |
| M | 499 | G159D | G | A | 0.00 | 0.00 | 0.00 | 0.11 | 0.55 |
| M | 808 | R262K | G | A | 0.00 | 0.07 | 0.07 | 0.09 | 0.00 |
| M | 818 | K265N | A | T | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| M | 925 a | N301I | A | T | 0.00 | 0.00 | 0.03 | 0.03 | 0.00 |
| M | 926 a | N301K | T | A | 0.06 | 0.34 | 0.40 | 0.49 | 0.90 |
| M | 1240 | D406G | A | G | 0.04 | 0.00 | 0.04 | 0.06 | 0.00 |
| M | 1473 | P484S | C | T | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 |
| M | 2480 | R819R | G | A | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
a
Nucleotide position 1 corresponds to the underlined base in the canonical RVFV antigenomic end sequence: 1‐ACACAAAG.
b
The variants at positions 31 and 32, and those at positions 925 and 926 are not linked.